Squarepoint Ops LLC Myriad Genetics Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 109,345 shares of MYGN stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,345

Previous 27,286 300.74%

Holding current value

$1.47 Million

Previous $667,000 348.58%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $1.97 Million - $2.35 Million	82,059 Added 300.74%	109,345 $2.99 Million
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $1.07 Million - $1.51 Million	-59,290 Reduced 68.48%	27,286 $667,000
Q1 2024 May 15, 2024	BUY	$17.59 - $23.59 $801,611 - $1.08 Million	45,572 Added 111.14%	86,576 $1.85 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $359,754 - $551,399	25,863 Added 170.81%	41,004 $784,000
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $202,256 - $273,667	-11,518 Reduced 43.2%	15,141 $350,000
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $2.13 Million - $3.32 Million	-139,725 Reduced 83.98%	26,659 $619,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $2.04 Million - $2.95 Million	140,496 Added 542.71%	166,384 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $471,420 - $721,757	25,888 New	25,888 $494,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $436,081 - $708,991	-35,862 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $575,898 - $755,067	-51,191 Reduced 58.8%	35,862 $468,000
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $930,596 - $1.44 Million	87,053 New	87,053 $987,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $161,161 - $270,270	-7,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $1.46 Million - $3.1 Million	-65,938 Reduced 89.54%	7,700 $220,000
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $1.67 Million - $2.58 Million	73,638 New	73,638 $2.05 Million
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $517,998 - $667,454	-19,235 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $70,689 - $118,273	2,596 Added 15.6%	19,235 $559,000
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $625,127 - $837,607	16,639 New	16,639 $765,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $1.18 Million - $1.71 Million	-42,560 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $505,793 - $719,479	17,544 Added 70.13%	42,560 $1.26 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $777,140 - $1.01 Million	-27,316 Reduced 52.2%	25,016 $859,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $1.26 Million - $1.89 Million	52,332	52,332 $1.89 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Myriad Genetics Inc Transaction History